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INTRODUCTION 
 
Pleural effusion is one of the common clinical disorders encountered in   
the medical wards. In a patient with pleural effusion diagnosis can be arrived by 
history, clinical examination and radiological techniques. Pleural effusion 
occurs due to various etiologies. 
Pleural effusion is of two different types depending on pathophysiology. 
They are Transudate and Exudate. To find out etiology, first step is to 
differentiate whether the pleural effusion is of exudate or transudate type. 
Etiology of pleural effusions differs in different parts of the world.  
In Indian scenario, infectious causes of pleural effusion particularly 
tuberculosis and pneumonic consolidation leading on to parapneumonic effusion 
will be the leading cause of pleural effusion.  
Though worldwide the incidence of empyema, has come down due to 
early initiation of antibiotic therapy, in India still many cases of empyema and 
loculated pleural effusion are encountered in tertiary care hospitals.  
After diagnosing pleural effusion in a patient, thoracentesis should be 
done under strict aseptic precautions and after getting concurrence from the 
patient. Pleural fluid aspirate is analysed for various parameters like protein, 
glucose, LDH etc. 
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Pleural fluid protein was used to differentiate exudate and transudate, 
which later on was found to be less sensitive. Then Light et al established 
diagnostic criteria to separate exudate and transudate in 1972. They used serum 
protein, serum LDH, pleural fluid protein and pleural fluid LDH, all these four 
parameters to differentiate exudative and transudate pleural effusion. Since then 
Light‘s criteria is used as the most accepted method to differentiate between 
exudate and transudate pleural effusion.  
Light et al established their criteria with sensitivity and specificity   of 
99% and 98%. But other community studies cannot reproduce this much of 
results and they showed results with lesser specificity of around 70-86%. 
Then newer parameters like ADA, interferon gamma assay, ANA, 
Rheumatoid factor, tumor markers etc. are analysed in the pleural fluid to 
separate exudates and transudate and they helped to arrive at an etiological 
diagnosis very easily. 
Apart from routine pleural fluid analysis of protein and LDH, various 
researchers studied role of various parameters to find out the set of indicators 
which will be simple and cost effective. Many newer investigations for 
diagnosis of pleural effusion are in pipeline but nothing has been widely 
accepted among the clinicians. 
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Various authors extended their work on establishing newer diagnostic 
tests to separate exudate and transudate. Pleural fluid cholesterol in isolation and 
in combination with other parameters was tried in many studies. Pleural fluid 
cholesterol and lactate dehydrogenase test was found to be the best alternative 
parameter and was in comparable to Light‘s criteria in differentiating exudate 
and transudate.  
So this study ‗PLEURAL FLUID CHOLESTEROL AND LACTATE   
DEHYDROGENASE TO DIFFERENTIATE EXUDATES AND 
TRANSUDATE AND COMPARING IT WITH LIGHT‘S CRITERIA‘ is taken  
to assess the usefulness of this test in differentiating pleural effusion into 
exudate and transudate and its comparison with established Light‘s criteria. 
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AIMS AND OBJECTIVES 
 
 
 
AIM 
 
To find the role of pleural fluid cholesterol and Lactate dehydrogenase in 
differentiating exudate and transudate. 
 
 
OBJECTIVES: 
 
 To find the diagnostic value of pleural fluid Cholesterol and Lactate 
dehydrogenase in differentiating exudative and transudative effusion 
and is compared with Light‘s criteria. 
 
 
 To find the place of pleural fluid cholesterol and Lactate 
dehydrogenase in diagnostic algorithm of pleural effusion. 
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REVIEW OF LITERATURE 
 
PLEURAL ANATOMY 
1
: 
Pleural cavity is derived from the primitive body cavity called coelom, 
which in turn is derived from primitive mesoderm of embryo. 
   
  The pleura have two membranes:   
 Inner visceral pleura cover the lung surface and inter lobar fissures.  
 Outer parietal pleura which lies outside the visceral pleura and it covers 
thoracic cavity‘s inner surface, diaphragm and mediastinum. 
The part of parietal pleura that covers inner surface of the ribs and intercostal 
muscles is called costal pleura, the one which covers the convex surface of the 
diaphragm is called diaphragmatic pleura. Cervical pleura is the one which extends 
into the neck and the part of the parietal pleura which covers mediastinum is called 
mediastinal pleura 
2
.  
Surface of the pleura is glistening, semitransparent and wet. The potential space 
between these two membranes is named as pleural space. 
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PLEURAL SPACE: 
         Pleural space is slit like which is filled with a thin layer of fluid, called 
pleural fluid. The function of this pleural fluid is mainly lubrication so as to reduce 
and eliminate friction forces. It allows movement of the lung with the chest wall 
during inspiratory and expiratory movements. 
                                                                                                                                      
FUNCTIONAL ANATOMY OF PLEURA
 3
: 
Whenever pleura are examined in light microscopy it is found to have five   
layers.  
        Five layers of pleura are: 
(i) The mesothelium  
(ii) Submesothelial connective tissue 
(iii) Layer of elastic tissue  
(iv) Another layer of loose connective tissue containing blood and lymph 
vessels and nerves. 
(v) Deep fibroelastic layer adherent to the underlying tissue. 
The two important functions that the connective tissue layer in the visceral 
pleura has: 
(a)  Elastic recoil of the lung, in expelling air from the lung,  
(b) Restricting the volume of the lung to be inflated, thereby protecting the 
lungs from over inflation. 
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MESOTHELIAL CELLS OF PLEURA: 
            Mesothelial cells covers surface of both parietal and visceral pleura. These 
cells are polygonal in shape. Surface of mesothelial cell is bushy and are 0.1 
micrometer in diameter and 3 micrometer in length. These mesothelial cells are 
metabolically active cells
4
. There exists tight junction between these mesothelial 
cells.                                               
 
BLOOD SUPPLY OF PLEURA 
5
: 
Parietal pleural Blood supply: 
Parietal pleural blood supply is very rich and supplied mainly by systemic   
vessels. 
 Intercostal and internal mammary vessels supply costal pleura. 
 Subclavian arteries supply cervical pleura. 
 Bronchial, internal mammary, mediastinal vessel supply mediastinal pleura. 
 Superior phrenic branch of internal mammary artery, posterior mediastinal 
artery which is from aorta in thorax, inferior phrenic artery a branch from 
abdominal aorta –all these supply diaphragmatic pleura. 
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VENOUS   DRAINAGE   OF   PARIETAL   PLEURA: 
        Venous drainage of parietal pleura is mainly to azygous vein. From there, it 
drains to superior vena cava. From diaphragmatic pleura some of the venous blood 
drains to inferior vena cava also. 
VISCERAL   PLEURAL   BLOOD SUPPLY: 
In human being visceral pleura is thick and the main blood supply is from 
bronchial artery. 
VENOUS DRAINAGE OF VISCERAL PLEURA: 
Venous blood from visceral pleura is drained mainly through pulmonary 
veins. 
 SURFACE ANATOMY OF PLEURA 
At the apices of the upper lobe and along the inner margins, the pleura lies 
very close to the lung. It rises 2-3 cm above the clavicle. 
In the lower aspect, pleura extends below the lung 4 to 5 cm anteriorly and 
9-10cm posteriorly. 
It lies at the level of 8
th
 rib in the mid clavicular line, 10
th
 rib in the mid 
axillary line, and the 12
th
 rib at the scapular line. 
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LYMPHATICS OF PLEURA 
6
: 
The costal pleura is surrounded by a lymphatic plexus which is mainly 
present in the intercostal spaces only and are absent below the ribs. These 
lymphatic vessels of the pleura covering the costal surface drain towards the 
lymph nodes those are present along the internal thoracic vessels and dorsally 
run towards the heads of the ribs to the internal intercostal nodes.  
From mediastinal pleura, the lymphatic vessels pass to the tracheobronchial 
and mediastinal nodes. The lymphatic drainage of the pleura that cover the 
diaphragm, pass to the parasternal, posterior mediastinal nodes and middle 
phrenic nodes. 
The parietal pleural lymphatic drainage plays a vital role in the formation 
and removal of fluid in pleural space, both in physiological and pathological 
condition. 
There are abundant lymphatic vessels in visceral pleura. These visceral 
pleural lymphatics form a plexus that intercommunicate with all vessels that run 
on the surface of the lung and they run towards the hilum and by penetrating the 
lung, they join the bronchial lymph vessels and then pass via the interlobular 
septa. 
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INNERVATION   OF   THE PLEURA
7
: 
 
PARIETAL   PLEURAL   INNERVATION: 
Nerve endings that are present in the costal and diaphragmatic parietal 
pleura are sensory nerve endings. The somatic type intercostal nerves supply the 
pleura which covers the costal surface and also the outer part of the pleura 
covering the diaphragm. So when these areas are stimulated, person will complaint 
of pain in the adjacent chest wall mainly. 
Phrenic nerve mainly innervates the central part of the diaphragm and pain is 
perceived in the ipsilateral shoulder if the central part of diaphragm is stimulated or 
irritated. 
 
VISCERAL PLEURAL INNERVATION: 
(i) There are no pain nerve fibers for visceral pleura and so it is pain 
insensitive. It can be manipulated without any unpleasant sensation. 
(ii) Vagus nerve by its pulmonary branches and sympathetic trunk supplies 
visceral pleura. 
Therefore, the main source of catchy pain is due to disease process that 
causes inflammatory reaction in the parietal pleura like tuberculous pleuritis, 
rheumatoid pleuritis etc. 
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PLEURAL FLUID: 
VOLUME
 8
: 
In physiological state, very minimal pleural fluid is present in between the 
two pleura. The mean amount of pleural fluid in the pleural space in normal human 
being is 8.4 +4.3 ml. The quantity of fluid in both the pleural spaces is similar. 
While expressing per kg of body mass, a non-smoking, normal individual has the 
total pleural fluid volume of 0.26 + 0.1 ml per Kg. 
 
CELLS IN PLEURAL FLUID: 
In humans, normally pleural fluid contains 75% macrophages and 25% are 
lymphocytes. Less than 2% of the cells that are present in pleural fluid are 
mesothelial cells, neutrophils and eosinophils.  
BIOCHEMICAL FACTORS: 
Protein:  
 Normally in humans, pleural fluid contains 1 to 2 gm. /dl of protein. 
 Hco3+: Normal level is 20 -25% higher than plasma. 
 K+: Identical to plasma. 
 Na+:   3-5% less than plasma. 
 Glucose:  Identical to plasma. 
 These electrolyte gradients suggest that an active process is involved in formation 
of pleural fluid.                                         
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PLEURAL FLUID PRESSURE AND DYNAMICS 
9, 10:
 
Pleural fluid movement within pleural membranes is mainly based on the 
balance of hydrostatic and oncotic pressure that exists between the 
microvasculature and the pleural space. Starling‘s Law describes the fluid 
movement across the pleural membranes. 
 
FORMATION OF PLEURAL FLUID: 
Pleural fluid is formed in the following manner and enters into the pleural 
cavity from, 
 The pleural capillaries 
 The interstitial spaces of the lung  
 The intrathoracic lymphatics  
 The intrathoracic blood vessels    
 The peritoneal cavity 
 
PLEURAL CAPILLARIES
9
: 
A gradient for fluid formation is normally present in the parietal pleura. In 
the parietal pleura the hydrostatic pressure is nearly 30 cm H2O. The pleural 
pressure is approximately - 5 cm H2O. So the net hydrostatic pressure will be 30 - 
(-5) = 35 cm H2O. This will favour the movement of fluid from the capillaries in 
the parietal pleura to the pleural space.   
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There is an oncotic pressure gradient opposing this hydrostatic pressure. 
This oncotic pressure in the plasma is nearly 34 cm H2O.                                                        
Normally, the pleural fluid contains a small amount of protein. It has an 
oncotic pressure of approximately 5 cm H2O and so it will yield a net oncotic 
pressure gradient of 34-5 = 29 cm H2O. This net gradient is 35-29 = 6 cm H2O, 
which favours the movement of pleural fluid to the pleural space from the 
capillaries in the parietal pleura. 
As the parietal pleura has systemic blood supply, it is found to be the source 
of normal pleural fluid. Moreover the parietal pleural microvessels will lie closer to 
the pleural space. The parietal pleural blood vessels have high micro vascular 
pressure as they drain into and are in continuity with systemic venules. 
 
PLEURAL FLUID FROM INTERSTITIUM:  
In diseased conditions like congestive heart failure
10
, the pleural fluid 
originates from the interstitial spaces of the lung. Most of the fluid from the 
interstitial space of the lung will be cleared through the pleural space. The volume 
of pleural fluid collected will be directly proportional to elevated wedge pressure. 
As the interstitial fluid increases, the sub pleural interstitial pressure will increase 
and the fluid will move via thick visceral pleura to the pleural space. 
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FROM   PERITONEAL   CAVITY 
11
: 
Pleural fluid accumulation can occur if there is free fluid in the peritoneal 
cavity and if there are openings in the diaphragm. Under these conditions, the fluid 
will flow from the peritoneal space to the pleural space because the pressure in the 
pleural cavity is less than the pressure in the peritoneal cavity. 
 
THORACIC   DUCT   INJURY: 
If the thoracic duct is disrupted, lymph will accumulate in the pleural space, 
producing a chylothorax. The rate of fluid accumulation with chylothorax can be 
more than 1,000 mL/day. 
                                                                  
PLEURAL FLUID ABSORPTION: 
  Lymphatic clearance 
  Clearance via capillaries in visceral pleura. 
 
LYMPHATIC   CLEARANCE 
12
 
The amount of fluid that can be cleared through these lymphatics is 
substantial. Clearance of pleural fluid through the pleural lymphatics explains the 
reason for fluid not accumulating in the pleural space in normal individuals. The 
pleural space has very good communication with the lymphatic vessels that are 
present in the parietal pleura, by means of stomas. Such stomas are not seen in the 
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visceral pleura. Cells, proteins and all the particulate matters are removed from the 
pleural space by the lymphatics in the parietal pleura. 
 Lymphatics in the pleural space have the ability to work to a maximum 
whenever excess fluid accumulates in the pleural cavity. Lymphatics have nearly 
28 times higher capacity to remove pleural fluid than they do during normal fluid 
formation. 
 
VISCERAL CAPILLARIES: 
Previously it was thought that the main route of exit of pleural fluid from 
pleural space is through visceral pleural capillaries. As visceral pleura in human 
beings is very thick later it was found that, most of the pleural fluid gets absorbed 
via lymphatics in the parietal pleura.                                                                                                                                                                                                                         
 
PATHOGENESIS OF   PLEURAL EFFUSION FORMATION:   
The basic pathogenesis in the accumulation of the excess pleural fluid which 
leads to the formation of the pleural effusion are:   
 Formation of increased pleural fluid.   
 Decreased absorption of the pleural fluid.  
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 (I). FORMATION   OF   INCREASED   PLEURAL FLUID: 
 
A.  INCREASED LUNG INTERSTITIAL FLUID 
13
 
 
 Pneumonic consolidation    
 
 Pulmonary vascular embolus 
 
 Left ventricular failure  
 
 
B. INCREASED PRESSURE IN INTRAPLEURAL VESSELS: 
 
When there is increased gradient between intrapleural and intravascular 
pressure, there is a tendency towards formation of increased pleural fluid. 
 
 Right or left ventricular failure. 
 
 Superior vena caval syndrome. 
 
 
 C.  INCREASED CAPILLARY PERMEABILITY: 
 Inflammation of the pleura 
 
 Elevated vascular endothelial growth factor level. 
  
D. INCREASED PROTEIN LEVEL  IN PLEURAL FLUID  
 
E. DECREASED LEVEL OF PLEURAL   PRESSURE 
 
 Atelectasis of lung. 
 Increased elastic recoil of the lung. 
 
 
                                                                                                                               
24 
 
 
F. LARGE VOLUME OF FLUID IN PERITONEAL CAVITY 
 
 Peritoneal dialysis. 
 Ascites 
G. THORACIC DUCT DISRUPTION 
 
H. THORACIC BLOOD VESSELS DISRUPTION  
  
 
(II) DECREASED ABSORPTION OF   PLEURAL FLUID:  
 
A. PARIETAL PLEURAL LYMPHATICS OBSTRUCTION 
The most common cause of a decrease in pleural fluid absorption is obstruction 
of the lymphatics draining the parietal pleura. Normally, the lymphatic flow from 
the pleural space is approximately 0.01 mL/kg/hour or 15 mL/day, because this is 
the amount of pleural fluid formed. However, the capacity of the lymphatics is 
approximately 0.20 mL/kg/hour or 300 mL/day. Lymphatic blockade is an 
important factor that contributes to the development of a malignant pleural 
effusion. 
 
B. INCREASED PRESSURE OF   SYSTEMIC VASCULATURE.  
 
 Superior venacava syndrome. 
 
 Right heart failure.         
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PLEURAL EFFUSION CAUSES: 
 
Pleural fluid that gets accumulated due to pathological reasons may be either 
an exudates or a transudate.  
TRANSUDATIVE PLEURAL EFFUSION
14
 
1. CONGESTIVE HEART FAILURE  
2. NEPHROTIC SYNDROME. 
3. HEPATIC HYDROTHORAX.  
4. PERITONEAL  DIALYSIS  
5. PULMONARY EMBOLISM 
6. SUPERIOR VENA CAVA OBSTRUCTION 
7. MYXEDEMA 
8. URINOTHORAX 
9. AMYLOIDOSIS 
10. SARCOIDOSIS 
11. LEAKAGE OF CEREBROSPINAL  FLUID  INTO  PLEURAL SPACE 
12. ATELECTASIS 
13. CENTRAL LINE MISPLACEMENT. 
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EXUDATIVE PLEURAL EFFUSION
15
  
 
1. MALIGNANT CAUSES:  
 
i. Mesothelioma  
ii. Lymphoma  
iii. Metastasis to lung and pleura 
2. INFECTIOUS DISEASES:  
i. Tuberculosis 
ii. Bacterial pneumonia 
iii. Invasive fungal disease 
iv. Viral infection 
v. Parasitic disease 
3. EMBOLI IN PULMONARY VASCULATURE. 
 
4. ABDOMINAL CONDITIONS  
 
i. Oesophageal perforation  
ii. Acute and chronic pancreatitis 
iii. Abdominal abscesses  
iv. Diaphragmatic hernia  
v. Post abdominal surgery 
vi. Variceal sclerotherapy 
vii. Hepatic transplantation  
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5. COLLAGEN VASCULAR DISEASES 
i. Rheumatoid pleuritis 
ii. SLE 
iii. Wegener‘s granulomatosis 
iv. Churg-Strauss syndrome 
 
6. POST CORONARY ARTERY BYPASS GRAFT OPERATION  
 
7. ASBESTOS RELATED LUNG DISEASES  
 
8. YELLOW NAIL SYNDROME 
9. UREMIC PLEURAL DISEASE 
10. SARCOID LUNG 
11. MEIGS SYNDROME 
12. DRUG INDUCED 
13. TRAPPED LUNG SYNDROME.  
14. RADIATION EXPOSURE  
15. HEMOTHORAX  
16. IATROGENIC INJURY  
17. OVARIAN HYPERSTIMULATION SYNDROME  
18. DISEASES OF PERICARDIUM  
19. CHYLOTHORAX  
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PLEURAL EFFUSION DUE TO DRUGS
16
: 
 
The pathogenesis of pleural effusion due to drugs is not understood well.  
The probable mechanism is 
          i)   Mesothelial injury due to oxidants 
          ii)   Acute hypersensitivity reactions 
         iii)  Direct dose related toxicity. 
Following drugs which are used commonly will lead on to pleural effusion. 
a. Nitrofurantoin  
b. Clozapine  
c. Methotrexate  
d. Interleukin  
e. Dantrolene  
f. Methysergide  
g. Bromocriptine  
h. Procarbazine  
i. Minoxidil 
j. Amiodarone. 
k. Interferons. 
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EVALUATION OF THE PATIENT WITH PLEURAL EFFUSION
17
 
Patients with pleural effusion may be asymptomatic or symptomatic. For 
proper evaluation of the various causes for pleural effusion the following details 
are needed. 
   i) Detailed history  
  ii) Physical examination  
  iii) Diagnostic radiology 
  iv) Pleural fluid analysis  
HISTORY 
If the patients are symptomatic the common symptoms will be chest pain, 
breathlessness and dry cough. If there is any underlying parenchymal disease, then 
patient will complaint of productive cough and fever. 
Pleuritic chest pain
18 
is described by the patient mainly as shooting pain or 
stabbing pain which is increased on deep inspiration, coughing or sneezing. This 
pleuritic chest pain radiates to the shoulder if the central part of the diaphragmatic 
pleura is inflamed. If costal pleura is involved it is more of a localized pain. 
 
BREATHLESSNESS: 
Patient‘s dyspnea in pleural effusion is due to decreased movement of the 
thoracic wall due to chest pain, collapse of the underlying lung or due to 
underlying parenchymal disease such as pneumonia.                                                     
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DRY COUGH: 
Dry cough is due to pleural inflammation or the compression of the lung by 
the fluid will bring the opposing bronchial walls into contact so that stimulating 
cough reflex. 
 ASYMPTOMATIC PATIENTS WITH PLEURAL EFFUSION 
a. Nephrotic syndrome 
b. Rheumatoid pleurisy 
c. Yellow nail syndrome 
d. Trapped lung 
e. Urinothorax 
f. Peritoneal dialysis 
g. Benign asbestos related  pleural effusion 
 
PATIENTS PRESENTING WITH TYPICAL SYMPTOMS 
a. Bacterial pneumonia 
b. Lupus pleuritis 
c. Pulmonary embolism 
d. Carcinomatous pleural effusion 
e. Malignant mesothelioma  
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PHYSICAL EXAMINATION 
19
  
 On  examination  of  the  patient , the  physical  signs  of  effusion  will depend on 
a) Volume of the pleural fluid 
b) Underlying lung compression 
c) Patency of bronchus 
Whenever about   500ml of pleural fluid is there, the findings will be 
a) Percussion dullness 
b) Decreased intensity of breath sounds 
c) Decreased fremitus. 
When more than 1000ml is there 
a) Bulging of the intercostal spaces. 
b) Decreased expansion of chest 
c) Dullness upto scapula 
d) Egophony at the upper level of pleural effusion. 
e) Absent vocal and tactile fremitus.                                                     
With massive pleural effusion  
a) Bronchial breath sounds at the apex. 
b) Liver and Spleen palpable due to depressed diaphragm. 
c) Totally absent breath sounds in entire hemithorax. 
d) Egophony at upper level of effusion. 
e) Bulging of intercostal spaces. 
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DIAGNOSIS OF PLEURAL EFFUSION BY RADIOLOGY 
The radiological tests used are 
a) Chest x ray 
b) Ultrasonogram chest 
c) CT-Chest. 
 
CHEST X RAY: 
The postero-anterior view, Lateral view, lateral decubitus view are the 
various views used to find out pleural fluid accumulation. 
a) Whenever 175ml of fluid gets accumulated, lateral costophrenic sulcus is 
blunted, but there are chances that even with 500ml fluid, there won‘t be any 
blunting. 
b) Costophrenic and cardiophrenic angles are obliterated. 
c) Fluid  may  get  collected  in  the  interlobar  fissures  which  will disappear  
on  treatment and  is called  as  vanishing  tumour  or phantom tumour. 
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MENISCUS SIGN 
In chest x ray
20
 postero anterior view, as the fluid increases in amount 
MENISCUS SIGN is seen. It is nothing but homogeneous opacity in lower zone 
with concave upward sloping which extends more laterally than medially. 
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SUBPULMONIC EFFUSION
21
 
             Pleural fluid will get accumulated in between diaphragm and lung surface 
and is called as subpulmonic effusion. Chest x ray features will be elevation of the 
ipsilateral hemidiaphragm, flattening of medial aspect and lateral peaking of the 
hemidiaphragm 
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LOCULATED EFFUSION 
Sometimes effusion is of loculated type, in which it is D shaped along lateral 
chest wall without obliterating costophrenic angle. 
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ULTRASONOGRAM CHEST 
Chest ultrasound will detect very minimal fluid in pleural space. It is seen as 
anechoic or hypoechoic shadow which is delineated from echogenic visceral 
pleura. 
                        
 Ultrasound is useful in detecting small effusion.  
 Loculated effusions are detected by ultrasonogram. 
 Ultrasound also detects tumors associated with pleura.  
 In diagnosing effusions in bedridden patients 
 Septations when present will be picked up by ultrasonogram.  
 Parietal and visceral pleural thickening, diaphragmatic thickening, nodules in 
diaphragm are detected along with effusion. 
 Hemorrhagic effusion or empyema is detected as homogenous echoes. 
 Ultrasonogram is useful in aspiration of minimal pleural fluid under direct 
guidance and for inserting chest tube in case of empyema.
22
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CT-THORAX 
 CT thorax is able to detect even very small effusion. CT will identify  presence  
of  inflammation  clearly  by  the  presence  of   thickening  of  visceral  and 
parietal pleura  and  enhancement  after  injection  of  the  contrast
23
 . CT also 
helps to find out any underlying lung parenchymal lesions.  
 A  pleural effusion  on  CT  will  look  like  dependent  sickle-shaped opacity , 
with a lower  attenuation  number  compared  to  adjacent  pleural  thickening  
or  mass.  
                                     
 Loculated  pleural  effusions  will be  lenticular shape  and  smooth  margins 
with displacement  of  adjacent  parenchyma. Loculated effusion which looks 
like a mass in chest x-ray can be clearly diagnosed with CT chest which shows 
homogenous attenuation.  
 Also CT chest is helpful in detecting mass lesion associated with pleural 
effusion .Contrast enhanced CT will show pleural enhancement and is more 
than 80% sensitive   and is also highly specific in evaluation of pleural effusion 
due to malignancy.                                   
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BILATERAL EFFUSION
24
: 
 
                           
 
 
1. CONGESTIVE HEART FAILURE  
2. MALIGNANCY. 
3. RHEUMATOLOGICAL DISEASES  
4. VIRAL INFECTIONS. .  
5. NEPHROTIC SYNDROME. 
6. EMBOLISM IN PULMONARY VESSELS. 
7. EOSINOPHILIC PNEUMONIA. 
8. CIRRHOSIS LIVER.  
9. AMYLOIDOSIS   
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RIGHT SIDED PLEURAL EFFUSION
25
: 
1. CONGESTIVE HEART FAILURE  
2. LIVER CIRHOSIS WITH PORTAL HYPERTENSION 
3. MEIGS SYNDROME 
4. SUBPHRENIC ABSCESS  
5. LIVER ABSCESS RUPTURE 
6. THORACIC DUCT INJURY BELOW D5 LEVEL. 
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LEFT SIDED EFFUSION: 
1. PANCREATITIS.  
2. THORACIC DUCT INJURY ABOVE D5 LEVEL. 
3. DRESSLERS SYNDROME.  
4. LEFT SUBDIAPHRAGMATIC ABSCESS.  
5. ESOPHAGEAL RUPTURE.  
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MASSIVE EFFUSION
26
 
Pleural effusion is said to be massive when it occupies entire hemithorax. 
 
 
 
CAUSES: 
1. Malignancy.  
2. Meig's syndrome 
3. Hepatic hydrothorax. 
4. Chylothorax. 
5. Hemothorax 
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THORACENTESIS
27
: 
Thoracentesis is defined as a drainage procedure in which needle is inserted 
into the pleural cavity to remove the fluid. It can be done as a bedside procedure, 
after explaining about it to the patient. It should be done under strict aseptic 
precaution. Thoracentesis is an important diagnostic procedure in a patient with 
pleural effusion. Pleural fluid tapping and analysis will help us to categorize as 
either transudate or exudate. Thoracentesis can also be done for therapeutic 
purpose to decrease respiratory distress in patients with massive effusion. There is 
insufficient data on the safety of this procedure in patients who are using 
anticoagulants or decreased platelet count. But studies show that it is very safe 
procedure, even with platelet count of less than 25000/mm
3
. It should be performed 
cautiously in patients who are on ventilators because of increased risk of tension 
pneumothorax. 
 
COMPLICATIONS OF THORACENTESIS: 
1. Pneumothorax  
2. Iatrogenic infections. 
3. Hemothorax. 
4. Pain shock. 
5.   Injury to the neurovascular bundle   
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DIAGNOSIS OF PROBABLE ETIOLOGY OF PLEURAL EFFUSION BY     
GROSS APPEARANCE, ODOUR AND CHARACTER OF PLEURAL FLUID 
GROSS APPEARANCE 
The transudate effusion will show a clear fluid and colour will be like a 
straw. Exudate will be more amber like and it appears cloudy. On prolonged 
standing ,a freshly drawn exudate effusion clots, on standing for a long time , while 
the transudative effusion which has less fibrin content remains in a fluid state. 
Bloody effusion can occur due damage to a vessel during thoracentesis and as a 
result of pleural or lung biopsy. 
If the fluid is red uniformly, the most probable cause is malignancy. Other 
conditions like tuberculosis, benign asbestos pleural effusion, leukemia, pulmonary 
infarction and rheumatoid pleuritis will also lead to hemorrhagic effusion. 
A frank hemothorax on aspiration will be seen in trauma, invasive 
procedures, pleural metastasis, anticoagulation for pulmonary infarction and 
catamenial hemothorax. 
Aspiration of white or milk like fluid is usually due to chylothorax or 
cholesterol effusion. Sometimes longstanding effusions of any cause may mimic 
chyle and is called as psudochyle. It may be due to the presence of globules of fat 
formed from dying cells.  
Brown colored fluid is due to long standing bloody fluid or amoebic liver 
abscess. 
                                                                                                                               
44 
 
CHARACTER OF PLEURAL FLUID: 
 Purulent fluid or gross pus is seen in frank empyema. 
 Viscous fluid is seen in mesothelioma. 
 Anchovy sauce like character in ruptured amoebic live abscess.  
 Turbid fluid character in inflammatory exudate. 
ODOUR OF FLUID: 
 Ammonia odour indicates urinothorax. 
 Putrid odour will be in anaerobic empyema. 
Therefore while doing thoracentesis itself, observation of the fluid color, 
character and odour, the probable type of pleural effusion and its possible cause 
can be ascertained. But further biochemical tests will be needed to confirm 
etiology.                                            
 
PLEURAL FLUID pH
28
: 
Normally pleural fluid is of alkaline character. pH decreases in pleural fluid 
if there is high metabolic activity in pleural space .pH  is considered low if value is 
less than 7.3 with a normal blood pH range. Most transudative effusion will have 
pH ranging from 7.45 to 7.55. But pH of most exudative effusion will be in the 
range of 7.30-7.45. 
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CAUSES OF pH less than 7.2 
1. Complicated  parapneumonic  effusion 
2. Oesophageal rupture. 
3. Rheumatoid pleuritis. 
4. Tuberculous pleuritis. 
5. Malignancy 
6. Hemothorax 
7. Systemic acidosis. 
8. Paragonimiasis 
9. Lupus  pleuritis 
10. Urinothorax 
 
Pleural fluid pH measurement will be of useful in deciding management of 
complicated pleural effusion. If the pH is less than 7.2 there is an indication for 
intercostal tube drainage. With  pleural  fluid  pH  we can determine  whether  
invasive  pleural  procedure  is  needed  or  not.                     
 
PLEURAL FLUID GLUCOSE
29
: 
Pleural fluid glucose level of <60 mg/dl or pleural fluid to serum glucose 
less than 0.5 is called low pleural fluid glucose. 
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COMMON CAUSES: 
1. Tuberculosis   
2. Parapneumonic effusion, 
3. Pleural tumors 
4. Rheumatoid disease.  
 
RARE CAUSES OF PLEURAL FLUID GLUCOSE <60mg/dl 
1. Parasitic infections like paragonimiasis infection  
2. Hemothorax 
3. Pleuritis in SLE  
4. Churg-Strauss syndrome. 
The lower the pleural fluid glucose, the more chance that we are dealing with a 
complicated parapneumonic effusion. Low glucose in parapneumonic effusion is 
associated with bad prognosis and is the indication for intercostal drainage tube 
insertion as the prime line of treatment.  
In rheumatoid pleurisy pleural fluid glucose level is less than 30 mg/dl in three 
fourth of patients. 
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 PLEURAL FLUID PROTEIN: 
The total amount of protein in pleural fluid was used to differentiate 
exudates and transudate previously. By comparing protein level in pleural fluid 
with that of serum protein we can diagnose exudative and transudative effusion. 
Tubercular effusion almost always will have protein concentration of more 
than 4 g/dl. Parapneumonic effusion and effusion due to malignancy will have 
wide range of pleural fluid protein level. 
When more than 7 gm. /dl of total protein is there in pleural fluid, we have 
to think of Waldenstroms macroglobulinemia and multiple myeloma. 
Light‘s criteria uses ratio of pleural fluid to serum protein as one of its 
criteria to differentiate exudate and transudate effusion. 
 
PLEURAL FLUID LDH 
Pleural fluid LDH is the important parameter in separation of pleural fluid 
into exudates and transudate. LDH is increased in pleural fluid whenever there is a 
effusion due to inflammatory process. It is included as one of the parameters in 
routinely used Light‘s criteria and also in combination with other parameters like 
protein and cholesterol. 
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Pleural fluid LDH concentration of >1000 IU/L can be found in one of the 
following disorders 
 Complicated parapneumonic effusion 
 Empyema  
 Pleural paragonimiasis. 
 Malignancy. 
 
PLEURAL FLUID TOTAL AND DIFFERENTIAL CELL COUNT
30
: 
Analysis of pleural fluid cell count is useful in many circumstances. If the 
total nucleated cell in effusion is more than 1000 per microliter, it is more in 
favour of exudates and in transudate it is mainly less than 1000 total nucleated 
cells. Pleural fluid nucleated cell count of more than 10000 is seen with 
parapneumonic effusion, acute pancreatitis and sub diaphragmatic abscess. 
In Transudative effusion predominant cell type are mononuclear cell, 
lymphocytes, macrophages and mesothelial cells. 
 
PLEURAL FLUID EOSINOPHILIA
31
: 
Eosinophilic pleural effusion is the one when pleural fluid eosinophil count 
is more than 10% of the total nucleated cells. Interleukin-5 acts as chemotactic 
factor for eosinophils and it will attract eosinophils from bone marrow into the 
pleural cavity.  
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INCREASED EOSINOPHILS WITH PERIPHERAL EOSINOPHILIA 
1. Hodgkin disease 
2. Fungal infection 
3. Paragonimiasis 
4. Benign asbestos pleural effusion 
5. Churg Strauss syndrome                                          
6. Tropical eosinophilia 
7. Drugs –Dantrolene, Nitrofurantoin. 
 
PLEURAL EOSINIPHILIA WITHOUT PERIPHERAL EOSINOPHILIA: 
1. Trauma 
2. Pulmonary infraction 
3. Pneumothorax 
4. Hemothorax 
PLEURAL FLUID NEUTROPHILIA 
1. Pulmonary infections 
2. Acute pulmonary embolism 
3. Very early stage of pleural effusion 
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LYMPHOCYTIC PLEURAL EFFUSION
32
: 
When lymphocytes in fluid are more than 80% of total cells it is called as 
lymphocytic effusion. 
1. Tuberculosis - commonest cause. 
2. Malignancy 
3. Chylothorax. 
4. Lymphoma.                                            
5. Yellow nail syndrome 
6. Sarcoidosis 
7. Rheumatoid disease 
 
MESOTHELIAL CELLS 
Pleural cavity is lined by mesothelial cells. They are present in small amount 
in normal pleural fluid. Mesothelial cells are uncommon in tuberculous pleural 
effusion. But patients with AIDS may have increased amount of mesothelial cells 
when they develop tuberculous pleural effusion.  
Mesothelial cells paucity is seen in following conditions 
1. Empyema 
2. Chemical pleurodesis 
3. Rheumatoid pleuritis 
4. Chronic malignant effusion.                                     
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LIPID ANALYSIS 
Analysis of pleural fluid triglyceride is must for the diagnosis of a suspected 
chylothorax. Pleural fluid triglyceride level of more than 110mg/dl will strongly 
support the diagnosis of chylothorax
33
. If triglyceride level is less than 50mg/dl, 
chances of chylothorax are less. 
If triglyceride level is between 50-110mg/dl the next step is to do lipoprotein 
electrophoresis to detect presence of chylomicrons. Presence of chylomicrons in 
lipoprotein analysis is diagnostic of chylothorax          
 
INTERFERON –GAMMA34 
CD4+ T cells produce Interferon –gamma which migrates into the pleural 
cavity. It is mainly used in diagnosing of tuberculous pleural effusion. Interferon-
gamma seems to be a useful defence mechanism. Interferon-gamma increases 
polymyristate acetate-induced hydrogen peroxide production in macrophages, so 
that facilitating elimination of intracellular parasites. This lymphokine will also 
inhibit mycobacterial growth in monocytes. Interferon gamma more than140pg/ml 
is significant for the diagnosis of tuberculous pleural effusion. 
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ADA IN PLEURAL FLUID
35
 
Adenosine deaminase is important in the degradation of purine and is also 
needed for lymphocyte differentiation. It is involved in maturation of monocyte-
macrophage lineage. In tuberculous effusions ADA level is higher than other 
exudative pleural effusion. 
The cut off level between 40 to 60 U/L is used with levels above indicating 
tuberculous pleural effusion. The sensitivity and specificity of ADA level in 
pleural fluid for the diagnosis of tuberculous pleural effusion is more than 90%.  
  
CAUSES OF ELEVATED ADA 
1. Tuberculous pleurisy 
2. Rheumatoid pleurisy 
3. Empyema 
4. After coronary bypass surgery 
5. Malignancy 
 
RARE CAUSES OF ELEVATED ADA 
1. Brucellosis 
2. Q fever 
ADA 1 and ADA 2 are the two isoenzymes in which ADA 2 is of monocyte and 
macrophage origin. 
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PLEURAL FLUID CHOLESTEROL
36 
Cholesterol level in pleural effusion is studied by many authors to 
differentiate exudate and transudate.  Cholesterol in pleural effusion is thought to 
be derived by  
1. Degenerating cells 
2. Increased permeability 
Cholesterol is synthesized by cells lining the pleura, depending on metabolic 
activity and needs. Also cholesterol in pleural fluid increases by degenerated 
leucocytes and erythrocytes. Increased vascular permeability of pleural capillaries 
also lead to increased pleural fluid cholesterol levels. 
Hamm and his coworkers studied about cholesterol in differentiating transudate 
and exudate and found it to be simple and cost effective. 
Cholesterol cut off value of more than 45mg/dl is taken in studies to 
differentiate exudative and transudative effusion. Pleural fluid cholesterol of more 
than 200mg/dl suggests chyliform effusion. 
 
PLEURAL FLUID AMYLASE
37
: 
The amylase rich pleural effusion is defined as a pleural fluid-serum amylase 
ratio more than 1 or increased amylase in pleural fluid more than upper limit of 
normal for serum amylase. 
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COMMON CAUSES: 
1. Pancreatic disease, 
2. Carcinoma 
3. Esophageal rupture.  
RARE CAUSES: 
1. Pneumonia 
2. Ruptured ectopic pregnancy 
3. Cirrhosis 
4. Hydronephrosis 
 
IMMUNOLOGICAL TESTS
38,39 
The two diseases where the immunological tests are useful are systemic 
lupus erythematosis and rheumatoid arthritis. Anti-nuclear antibody (ANA) and 
Rheumatoid factor (RF) are assessed in pleural fluid. 
ANA IN PLEURAL FLUID 
Pleural fluid ANA of more than 1: 160 or pleural fluid to serum ANA more 
than 1will is suggestive of systemic lupus erythematosis. 
Rh FACTOR IN PLEURAL FLUID 
When Rh factor in pleural fluid is more than 1:320 and also greater than 
serum rheumatoid factor, it is likely due to rheumatoid arthritis. 
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DIFFERENTIATION OF EXUDATIVE AND TRANSUDATIVE PLEURAL 
EFFUSION:
40,41 
After complete analysis of pleural fluid, the important step will be 
differentiation of pleural effusion into exudates and transudate, based on the 
various parameters tested in the pleural fluid.
 
Initially pleural fluid specific gravity was taken into account to differentiate 
exudative and transudative effusion. Then pleural fluid protein was taken as an 
important parameter which supplanted measurement of specific gravity.
 
Later it was found that, differentiating exudates and transudate using pleural 
fluid protein alone was not quite sensitive and may lead on to misclassification. 
Light‘s and his coworkers published that pleural fluid protein and LDH to be 
measured to compare it with serum values in a combination test that used an ―or‖ 
diagnostic test. 
LIGHT’S CRITERIA41 
1. Pleural fluid to serum protein ratio more than 0.5 
2. Pleural fluid to serum LDH ratio more than 0.6 
3. Pleural fluid LDH more than 2/3 of upper limit of normal serum LDH. 
Presence of exudative effusion is established by Light‘s criteria, if any one of 
the above is present. Transudative effusion will not meet any criteria. 
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Most of the exudates were correctly diagnosed by Light‘s criteria. In patients 
with cirrhosis and congestive heart failure, who are started on diuretics, light‘s 
criteria misclassified transudate as exudates. Though it has high sensitivity of 98% 
specificity was found to be 74% in subsequent validation studies. 
 
It was observed by Chakko
42
 and his coworkers that transudative pleural 
effusions that is due to congestive heart failure, after treating with diuretics, light‘s 
criteria will show it as exudate
44
. This is due to rapid pleural fluid absorption from 
pleural space. 
 
To overcome this pitfall of Light‘s criteria, Roth et all suggested to do serum 
effusion albumin gradient but that also needs blood sampling. 
 
As Light‘s criteria has high sensitivity but low specificity, many other studies 
are also done to find out simple tests, comparable to lights criteria to differentiate 
exudate and transudate. Pleural fluid cholesterol, pleural fluid cholesterol and 
LDH, bilirubin level in pleural fluid, soluble leukocyte selectin, cytokines, uric 
acid and pleural fluid to serum cholinesterase are the some new tests studied.  
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PLEURAL FLUID CHOLESTEROL AND LDH TO DIFFERENTIATE 
EXUDATE AND TRANSUDATE
 
Pleural fluid cholesterol and LDH is studied to separate exudates and 
transudate. Marina Costa and M.Quironga
43
 worked on finding out simple set of 
indicators to separate exudate and transudate. They worked on pleural fluid 
cholesterol and other parameters with cholesterol, to determine whether similar 
results can be attained with Light et al. They found that pleural fluid cholesterol of 
>45mg/dl and LDH of >200 IU/L is simple and presence of any one or both of 
these parameters is diagnostic of exudate. This test is comparable to light‘s criteria.  
Rohit Rungta
44
 also studied about pleural fluid biochemical parameters and 
analysed them with pleural fluid cholesterol. He found that pleural fluid analysis of 
cholesterol and LDH with cut off value of > 45mg/dl and > 200 IU/L respectively 
has higher sensitivity and specificity than any other combinations in differentiating 
exudate and transudate. 
So this study ‗PLEURAL FLUID CHOLESTEROL AND LACTATE 
DEHYDROGENASE TO DIFFERENTIATE EXUDATES AND TRANSUDATE 
AND COMPARING IT WITH LIGHT‘S CRITERIA‘ is taken to assess the 
diagnostic utility of this test, in separation of pleural effusion to exudate and 
transudate in comparison with Light‘s criteria.  
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MATERIALS AND 
METHODS 
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MATERIALS AND METHODS 
SETTING 
This study is conducted in the patients admitted in Government Royapettah 
hospital. 
STUDY POPULATION 
Patients admitted as in-patients in medical wards and diagnosed to have 
pleural effusion clinically and radiologically. 
TYPE OF THE STUDY - Cross sectional study 
HAZARDS OF THE STUDY - Nil 
INCLUSION CRITERIA 
 Newly diagnosed cases of pleural effusion 
EXCLUSION CRITERIA 
 Traumatic pleural effusion 
 Patients already started on treatment for pleural effusion 
SAMPLE SIZE 
50 patients admitted and diagnosed to have pleural effusion in the medical 
ward. 
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STUDY DURATION 
From January 2015 to August 2015 
METHODS AND DATA COLLECTION 
After taking detailed history from the patient, they are subjected to complete 
clinical examination. All the patients with suspected pleural effusion clinically are 
further subjected to radiological investigations, mainly chest x ray and then ultra-
sonogram chest if needed, to confirm the presence of pleural effusion. 
The thoracentesis procedure was explained to the patient. After getting 
consent from the patient, under strict aseptic precaution, thoracentesis was done 
and pleural fluid was sent for analysis. 
Pleural fluid analysis comprising of glucose, protein, LDH, cholesterol, 
cytology, AFB, gram stain was done. Complete blood count, blood urea, serum 
creatinine, liver function tests, serum protein and serum LDH, serum cholesterol 
was done. Sputum gram stain and AFB was done. 
Light‘s criteria was used to classify the patients into exudate and transudate. 
Transudate group were further subjected to find the cause of transudate by 
subjecting them to ultrasound abdomen, echocardiogram etc. 
Pleural fluid cholesterol of more than 45mg/dl and LDH of more than 
200IU/L is taken as cut off value and presence of any one or both parameter is 
diagnostic of exudate, as per previous study references. 
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STATISTICAL ANALYSIS 
 
All the observations in this study analysed statistically using software. 
Sensitivity, Specificity, Positive predictive value and Negative predictive value of 
Pleural fluid cholesterol and LDH test is analysed with SPSS 20.0 software and 
CHI-SQUARE test is used. Measure of agreement between two test and kappa 
value is calculated. P value of <0.05 is taken as significant. 
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OBSERVATION  
AND  
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OBSERVATION AND ANALYSIS 
 
AGE DISTRIBUTION 
10 cases out of fifty cases in the study are below the age of thirty years 
comprising 20% of  total cases 17 cases are between 31-40 yrs comprising 34% of 
total cases 6 cases are between 41-50yrs comprising 12% of total cases. 10 cases 
are between 50-60 yrs comprising 20% of total cases. 7 cases are above 60 yrs 
comprising 14% of total cases. 
 
 
AGE IN YEARS FREQUENCY PERCENT 
Below 30 10 20.0 
31-40 17 34.0 
41-50 6 12.0 
51-60 10 20.0 
61-70 7 14.0 
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SEX 
Among 50 patients in the study males are 26 and females are 24 cases 
comprising 52% and 48% respectively. 
 
GENDER FREQUENCY PERCENT 
Male 26 52.0 
Female 24 48.0 
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EXUDATE VS TRANSUDATE 
 
TYPE  Frequency Percent 
Exudate 40 80.0 
Transudate 10 20.0 
 
 
 
 
         
 
 
 
 
40 
10 
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67 
 
 
ETIOLOGY 
 
 Out of 50 cases tuberculosis comprises 21 cases with 42% 
 Parapneumonic effusion  cases are 11 with 22% 
 Transudates are 10 cases with 20% 
 Malignancy are 6 cases with 12% 
 Empyema comprises 2 cases with 4%. 
 
TYPE FREQUENCY PERCENT 
Tuberculosis 21 42.0 
Para Pneumonic 11 22.0 
Transudate 10 20.0 
Malignancy 6 12.0 
Empyema 2 4.0 
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ETIOLOGY IN EXUDATE 
 
ETIOLOGY Frequency 
TB 21 
Para Pneumonic 
 
11 
 
Malignancy 
6 
 
Empyema 
2 
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DISTRIBUTION OF CHEST XRAY FINDING 
Out of 50 cases chest x ray showed right sided pleural effusion in 28 cases 
comprising 56%, 17 cases of left sided pleural effusion with 34%, 5 cases of 
bilateral effusion which comprises 10%. 
 
SIDE FREQUENCY PERCENT 
Left 17 34.0 
Right 28 56.0 
Bilateral 5 10.0 
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PLEURAL FLUID GRAM STAIN 
 
GRAM STAIN FREQUENCY PERCENT 
Positive 2 4.0 
Negative 48 96.0 
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PLEURAL FLUID CYTOLOGY 
Lymphocytic pleural effusion is 21 cases out of 50 cases comprising 42%. 
All the lymphocytic cases are tuberculous etiology. 13 pleural effusions are 
neutrophilic in nature which comprises 26%. 11neutrophilic effusions are 
parapneumonic and 2 cases of empyema. 6 cases are malignant pleural effusion 
with 12% of total. 10 pleural effusions are acellular with 20% of total. All the 
acellular pleural effusions are transudate in nature. 
 
CYTOLOGY FREQUENCY PERCENT 
Nil 10 20.0 
Lymphocytes 21 42.0 
Neutrophil 13 26.0 
Malignant 6 12.0 
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SPUTUM GRAM STAINS: 
Only 10 cases are sputum gram stain positive in which three are gram 
negative bacilli and seven cases are gram positive cocci. 
 
GRAM STAIN FREQUENCY PERCENT 
No organism 40 80.0 
Negative Bacilli 3 6.0 
Positive Cocci 7 14.0 
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LIGHTS CRITERIA  
Out of 50 cases, Light‘s criteria diagnosed 40 cases as exudates which is 
80% of total cases and 10 cases as transudates which is 20% of total cases. 
 
TYPE FREQUENCY PERCENT 
Exudate 40 80.0 
Transudate 10 20.0 
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MEAN SERUM PROTEIN LEVEL  
Mean serum protein level in tuberculous effusion patients is 6.5gm/dl. In 
Para pneumonic effusion cases mean serum protein level is 6.6gm/dl. Mean serum 
protein level in transudative effusion cases is 5gm/dl. In patients with malignant 
effusion, the mean serum protein level is 5.9 gm. /dl. In empyema patients, mean 
serum protein level is 6.6gm/dl. 
 
 
 
ETIOLOGY N 
MEAN 
(gm./dl) 
SD 
TB 21 6.557 0.263 
Para Pneumonic 11 6.636 0.366 
Transudate 10 5.840 0.636 
Malignancy 6 5.967 0.196 
Empyema 2 6.600 0.282 
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MEAN SERUM LDH LEVEL  
In patients with tuberculous pleural effusion the mean serum LDH level is 
351IU/L. In patients with parapneumonic effusion, the mean serum LDH value is 
358 IU/L. In transudative effusion patients the mean serum LDH value is 331IU/L. 
In malignant effusion cases, the mean serum LDH is 384 IU/L. In empyema cases, 
the mean serum LDH level is 385 IU/L. 
 
 
ETIOLOGY N 
MEAN 
(IU/L) 
SD 
TB 21 351.33 30.622 
Para Pneumonic 11 358.18 28.375 
Transudate 10 331.80 16.612 
Malignancy 6 384.00 11.524 
Empyema 2 385.00 15.556 
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MEAN SERUM CHOLESTEROL LEVEL  
In tuberculous pleural effusion patients, the mean value of serum cholesterol 
is 174mg/dl. In parapneumonic effusion patients, the mean level is 181mg/dl. In 
transudative effusion cases, the mean serum cholesterol is found to be 208mg/dl. In 
malignant cases, the mean serum cholesterol level is 190mg/dl. In cases of 
empyema, the mean level is found to be 173 mg /dl. 
 
 
ETIOLOGY N 
MEAN 
(Mg/dl) 
SD 
TB 21 174.33 11.521 
Para Pneumonic 11 181.82 10.638 
Transudate 10 208.40 31.690 
Malignancy 6 190.67 7.866 
Empyema 2 173.00 18.385 
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MEAN PLEURAL FLUID PROTEIN LEVEL  
  Mean pleural fluid protein level in tuberculous effusion patients is 4.3gm/dl. In 
parapneumonic effusion patients, the mean pleural fluid protein level is 4.7 gm/dl. 
Trasudative pleural effusion patients showed pleural fluid mean protein level of 
2.4gm/dl. Maliganat cases showed pleural fluid protein value of 6.1gm/dl. In 
empyema patients, the mean value is 6.1gm/dl. 
 
 
 
ETIOLOGY N 
MEAN 
(gm./dl) 
SD 
TB 21 4.386 0.377 
Para Pneumonic 11 4.791 0.270 
Transudate 10 2.400 0.722 
Malignancy 6 6.167 0.367 
Empyema 2 6.100 0.424 
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MEAN PLEURAL FLUID LDH LEVEL  
288 IU/L is the mean pleural fluid LDH value in tuberculous effusion cases. 
In parapneumonic effusion patients, the mean pleural fluid LDH value is 342 IU/L. 
In transudates the mean pleural fluid LDH is 137 IU/L. In empyema, the mean 
pleural fluid LDH is 424 IU/L. In malignant effusion, the mean pleural fluid LDH 
is found to be 621 IU/L. 
 
 
ETIOLOGY N 
MEAN 
(IU/L) 
SD 
TB 21 288.48 11.677 
Para Pneumonic 11 342.18 35.535 
Transudate 10 137.40 26.298 
Malignancy 6 621.67 44.279 
Empyema 2 424.00 .000 
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MEAN PLEURAL FLUID CHOLESTEROL  
In pleural effusion due to tuberculosis, the mean pleural fluid cholesterol is 
63mg/dl. In parapneumonic effusion patients, the mean value of pleural fluid 
cholesterol is 67mg/dl. In transudates, the mean pleural fluid cholesterol is found 
to be 36mg /dl. In malignant pleural effusion cases, the mean pleural fluid 
cholesterol value is 85mg/dl. In empyema cases, the mean value is 73mg/dl. 
 
ETIOLOGY N MEAN SD 
TB 21 63.71 4.529 
Para Pneumonic 11 67.09 4.323 
Transudate 10 36.40 3.502 
Malignancy 6 85.33 6.154 
Empyema 2 73.00 4.243 
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ACTUAL ETIOLOGY VS LIGHT’S CRITERIA VS PLEURAL FLUID 
CHOLESTEROL AND LDH TEST 
Out of 50 total cases, as per etiology, 40 cases were exudates and light‘s 
criteria diagnosed all the 40 cases correctly as exudates. The newer test pleural 
fluid cholesterol and LDH, diagnosed 38 cases correctly as exudates and two cases 
were misclassified as transudates. Out of 10 transudate cases by etiology, Light‘s 
diagnosed all the 10 cases as transudates correctly. Pleural fluid cholesterol and 
LDH test diagnosed 8 cases correctly as transudates and misclassified two 
transudates as exudates. 
                               
LIGHT’S CRITERIA  VS  ACTUAL  ETIOLOGY 
 
 
 
ACTUAL ETIOLOGY 
Total 
P 
VALUE EXUDATE TRANSUDATE 
LIGHTS 
CRITERIA 
 
EXUDATE 40 0 40 
0.001** 
TRANSUDATE 0 10 10 
Total 40 10 50 
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LIGHT’S CRITERIA  VS  ACTUAL  ETIOLOGY 
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PLEURAL FLUID CHOLESTEROL AND LDH TEST  
VS  
ACTUAL ETIOLOGY 
 
 
ACTUAL ETIOLOGY 
Total 
P 
VALUE EXUDATE TRANSUDATE 
PLEURAL FLUID 
CHOLESTEROL + 
LDH  
EXUDATE 38 2 40 
0.001
**
 TRANSUDATE 2 8 10 
Total 40 10 50 
 
 
Pleural fluid cholesterol and ldh 
Transudate Exudate 
Count 
40 
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LIGHT’S CRITERIA 
VS 
PLEURAL FLUID CHOLESTEROL AND LDH TEST 
 
As already seen, the routinely used light‘s criteria diagnosed 40 cases as 
exudates. The pleural fluid cholesterol and LDH test diagnosed 38 cases as 
exudates out of 40 cases diagnosed by Light‘s criteria as exudates. Two exudates 
were only misclassified as transudates. 
 
Similarly pleural fluid cholesterol and LDH test misclassified only two 
transudates as exudates, which were diagnosed as transudates by Light‘s criteria. 
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PLEURAL FLUID 
CHOLESTEROL+LDH Total P VALUE 
EXUDATE TRANSUDATE 
LIGHTS 
CRITERIA 
 
EXUDATE 38 2 40 
0.001
**
 
TRANSUDAT
E 
2 8 10 
Total 40 10 50 
                                            
  
By this 2*2 table pleural fluid cholesterol and LDH was compared with the 
standard LIGHTS criteria and the results showed 
 
 Sensitivity to be 95% 
 Specificity to be 80% 
 Positive predictive value 95% 
 Negative predictive value 80%. 
 P value of <0.001**  was significant 
 In measure of agreement, kappa value is 0.75 which shows good correlation. 
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DISCUSSION 
Out of 50 cases taken into the study, 40 cases were exudates and 10 cases 
were transudates etiologically. 26 patients are male and 24 patients are female out 
of fifty patients. Most of the patients are between 30 to 60 years. Only 7 cases were 
above 60 years and 10 cases below 30 years. 
 
In this study, it was found that tuberculosis is found to be the most common 
cause of pleural effusion and parapneumonic effusion came next. Transudative 
effusion comprises only 20%. X ray chest showed right sided pleural effusion in 
56% of cases and left sided effusion in 34% of cases. Bilateral effusion was seen in 
10% of cases, all of which were due to transudative etiology. 
 
In this study, it is found that lymphocytic effusion predominates and all are 
due to tuberculosis etiology. The next one is neutrophilic effusion which is due to 
parapneumonic etiology and empyema. All the transudative effusions were 
acellular. 
 
Sputum AFB was negative in all the patients in the study. Sputum gram stain 
is positive in ten cases, in which three are gram negative bacilli and seven are gram 
positive cocci. All were seen with parapneumonic effusion. 
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Mean serum protein level is found to be high in effusion due to 
parapneumonic cause and empyema with 6.6gm/dl. Mean serum LDH is higher in 
malignant pleural effusion and empyema with 384 IU/L and 385 IU/L respectively. 
Mean serum cholesterol is higher in transudative effusion patients with value of 
208mg/dl. 
Mean pleural fluid protein is 2.4gm/dl in transudative effusion. In exudative 
effusion, mean pleural fluid protein is found to be highest in malignancy and 
empyema with value of 6.1gm/dl. In tuberculosis it is 4.3gm/dl and in 
parapneumonic 4.7gm/dl. 
Mean Pleural fluid LDH in transudate is 137 IU/L. In malignancy, it is 
highest with 621 IU/L and in empyema, it is 424 IU/L. In tuberculosis, it is 288 
IU/L and in parapneumonic effusion, it is 342 IU/L. 
Mean pleural fluid cholesterol is highest in malignant pleural effusion with 
85mg/dl and next comes empyema with 73mg/dl. In transudates, it is 36mg/dl. In 
tuberculosis cases, it is 63mg/dl and in parapneumonic effusion, it is 67mg/dl. 
Light‘s criteria diagnosed 40 cases as exudates which correctly matched 
with etiological diagnosis. In the same way, it diagnosed ten cases as transudates 
which also correctly matched with etiological diagnosis. So light‘s criteria showed 
100% sensitivity and 100% specificity according to this study. The point to be 
noted is pleural fluid analysis was done even before starting diuretics. 
                                                                                                                               
95 
 
 
The pleural fluid cholesterol and LDH test diagnosed 38 cases as exudates 
when compared with lights criteria and two exudates were only misclassified as 
transudates. In the same way, this test diagnosed 8 cases as transudates correctly 
when compared with Light‘s criteria and 2 transudates were misclassified as 
exudates. 
 
COMPARITIVE ANALYSIS OF LIGHT’S CRITERIA AND PLEURAL 
FLUID CHOLESTEROL AND LDH TEST 
When pleural fluid cholesterol and LDH test is compared with routinely 
used Light‘s criteria in a 2 * 2 table, the pleural fluid cholesterol and LDH test 
showed sensitivity of  95%  and specificity of 80%, positive predictive value of 
95% and negative predictive value of 80%. 
Study conducted by Marina costa MD; Teresa  Quiroga MD, showed 99% 
sensitivity and 98% specificity for pleural fluid cholesterol and LDH combination 
in differentiating exudate and transudate. Study by Rohit Rungta also showed 
sensitivity of 99% and specificity of 98%. Our present study showed 95% 
sensitivity and 80% specificity. 
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MEASURE OF AGREEMENT BETWEEN LIGHT’S CRITERIA  
AND  
PLEURAL FLUID CHOLESTEROL AND LDH TEST 
 
 VALUE P VALUE 
Measure of Agreement Kappa 0.750 <0.01** 
 N of Valid Cases 50 
 
Measure of agreement between these two tests is calculated using kappa 
value which also showed significant agreement between these two tests with kappa 
factor of 0.75 and P value of  0.01** which is highly significant. 
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CONCLUSION 
 
 Light‘s criteria is the most accepted criteria for differentiating between 
exudates and transudate in pleural effusion.  
 
 It uses four parameters serum protein, serum LDH, pleural fluid protein and 
pleural fluid LDH. 
 
 
 Pleural fluid cholesterol and LDH test in pleural fluid with cholesterol 
>45mg/dl and LDH >200 IU/L showed 95% sensitivity and 80% specificity in 
diagnosing exudates, which is comparable with Light‘s criteria, with 
significant measure of agreement between the two, with significant P value of  
<0.01
**
. 
 
 Pleural fluid cholesterol and LDH test is useful to differentiate pleural fluid 
exudate and transudate with the advantage of requiring only two laboratory 
parameters and no simultaneous blood sample especially in countries like 
India, where financial and technical constraints are immense.  
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LIMITATIONS OF THE STUDY 
 
 This study comprises only 50 patients which is a very limited number. 
 Pleural fluid analysis was done in newly diagnosed patients who were not 
started on any diuretics. Therefore the sensitivity and specificity of light‘s 
criteria is very high in this study. 
 The sensitivity and specificity of the new test should further be evaluated by 
involving a larger number of subjects. 
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AGE 
 
 
SEX COMPLAIN TC ESR SR.PRO SR.LDH SR.CHO RBS PLEF.PRO 
25 
 
M F,CP-RT 4,500 40 6.6 386 165 140 4.2 
32 
 
M F,CP-RT 4,700 44 6.5 374 170 130 4.0 
60 
 
F F,SP,D 13,400 42 7.0 380 200 176 4.4 
50 
 
M D,PE 3,800 24 5.2 300 210 182 2.1 
18 
 
F CP.LT 5,600 38 6.8 360 154 140 4.3 
55 
 
F D,CP.LT 3,800 30 6.0 384 206 208 5.8 
33 
 
F F,CP,LOW 6,400 52 6.7 368 172 120 4.2 
65 
 
M D,PE 4,400 18 6.0 388 246 184 2.2 
22 
 
F F,SP,D 16,400 22 6.8 346 166 132 5.1 
32 
 
M CP.RT 4,700 30 6.6 340 150 166 3.8 
64 
 
M D,LOW 5,100 28 6.2 400 190 212 6.6 
20 
 
F D,F 6,800 32 6.2 346 166 126 3.6 
43 
 
F F,SP,D 13,800 30 6.0 390 198 264 4.8 
64 
 
M D,AD,PE 4,600 18 6.1 326 224 186 2.4 
38 
 
F F,CP 6,400 46 6.4 346 182 166 4.0 
42 
 
M D,PE 3,800 20 5.0 386 144 110 2.1 
40 
 
F F,CP.RT,SP 20,600 22 6.8 374 160 242 6.4 
65 
 
M D,AD,PE 6,200 18 6.5 356 240 176 3.2 
57 
 
F F,SP,CP.RT 18,200 18 6.8 378 172 196 4.8 
35 
 
M CP.RT,F 7,200 54 7.0 388 178 166 4.8 
65 
 
F D, 5,600 20 6.0 376 186 146 6.6 
28 
 
F F,D 4,500 46 6.8 384 164 124 5.2 
55 
 
M D,AD,PE 3,600 16 4.8 346 178 106 2.2 
34 
 
M D,F 5,200 18 7.0 374 184 134 4.8 
60 
 
F F,CP.LT,SP,C 18,600 20 6.4 396 186 244 5.8 
34 
 
M D,LOW 12,000 26 6.0 374 184 148 6.0 
27 
 
F F,CP 4,400 36 6.4 346 174 176 4.6 
45 
 
M F,CPLT,SP 12,600 22 7.2 376 186 166 5.2 
33 
 
M F,LOW 3,800 14 6.7 354 186 126 4.4 
55 
 
F D,PE 4,200 14 6.6 346 220 144 3.1 
60 
 
M F,CP,SP 14,600 18 7.0 364 190 134 5.0 
18 
 
F F,CP.RT,SP 4,200 44 6.8 358 166 116 4.8 
38 
 
M F,C,CP,SP 14,400 16 6.6 374 176 138 4.4 
40 
 
M F,LOW 4,200 18 6.8 384 180 160 4.4 
55 
 
F D,LOW 7,400 22 5.6 374 190 182 6.2 
36 
 
M D,F 5,500 34 6.4 326 186 134 4.8 
40 
 
F D,F,C,CP 17,600 22 6.2 302 180 112 5.0 
55 
 
M D,AD,PE 3,200 12 5.8 324 180 96 2.2 
24 
 
F D,F,CP 3,800 34 6.4 320 184 122 4.2 
50 
 
F D,CP.LT 7,400 44 6.4 326 176 164 4.4 
56 
 
M D,LOW,CPLT 5,500 18 6.0 396 188 264 5.8 
35 
 
M F,D 5,200 32 6.2 284 198 134 4.4 
28 
 
F F,LOW 3,400 24 6.6 296 176 112 4.6 
70 
 
M D,PE 4,400 14 6.6 346 226 156 1.8 
38 
 
M F,C,CP,SP 14,200 16 6.4 326 176 166 4.8 
32 
 
F F 3,800 22 6.4 376 180 116 4.6 
65 
 
F D,AD,PE 4,400 12 6.0 326 216 226 1.6 
36 
 
M F,CP 5,400 14 6.0 324 184 144 4.2 
45 
 
M F,C,CP,SP 6,600 18 6.6 328 176 156 4.6 
30 
 
F F,CP.RT 4,800 38 6.4 394 166 146 4.4 
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PLEF.LDH 
 
PLEF.CHO PLEF.GLU PLEF.GRA PLEF.AFB PLEF.CYT SP.GRAM 
284 
 
62 66 Negative Negative Lymphocytes Negative 
278 
 
66 58 Negative Negative Lymphocytes Negative 
368 
 
74 48 Negative Negative Neutrophil Positive Cocci 
96 
 
38 66 Negative Negative Nil Negative 
284 
 
68 54 Negative Negative Lymphocytes Negative 
612 
 
82 40 Negative Negative Malignant Negative 
288 
 
72 48 Negative Negative Lymphocytes Negative 
212 
 
52 64 Negative Negative Nil Negative 
384 
 
70 40 Negative Negative Neutrophil Positive Cocci 
292 
 
62 50 Negative Negative Lymphocytes Negative 
602 
 
92 42 Negative Negative Malignant Negative 
178 
 
40 52 Negative Negative Lymphocytes Negative 
374 
 
72 42 Negative Negative Neutrophil Negative Bacilli 
110 
 
30 62 Negative Negative Nil Negative 
284 
 
66 54 Negative Negative Lymphocytes Negative 
206 
 
54 52 Negative Negative Nil Negative 
424 
 
70 38 Positive Negative Neutrophil Positive Cocci 
154 
 
40 60 Negative Negative Nil Negative 
386 
 
70 42 Negative Negative Neutrophil Negative Bacilli 
316 
 
68 56 Negative Negative Lymphocytes Negative 
614 
 
92 44 Negative Negative Malignant Negative 
324 
 
58 52 Negative Negative Lymphocytes Negative 
166 
 
40 64 Negative Negative Nil Negative 
284 
 
54 60 Negative Negative Lymphocytes Negative 
424 
 
76 48 Positive Negative Neutrophil Positive Cocci 
696 
 
88 40 Negative Negative Malignant Negative 
288 
 
56 52 Negative Negative Lymphocytes Negative 
334 
 
68 38 Negative Negative Neutrophil Negative 
280 
 
60 54 Negative Negative Lymphocytes Negative 
166 
 
38 64 Negative Negative Nil Negative 
324 
 
68 38 Negative Negative Neutrophil Negative Bacilli 
198 
 
42 54 Negative Negative Lymphocytes Negative 
312 
 
66 48 Negative Negative Neutrophil Positive Cocci 
286 
 
68 52 Negative Negative Lymphocytes Negative 
642 
 
80 36 Negative Negative Malignant Negative 
286 
 
66 56 Negative Negative Lymphocytes Negative 
374 
 
64 48 Negative Negative Neutrophil Positive Cocci 
146 
 
40 56 Negative Negative Nil Negative 
280 
 
68 54 Negative Negative Lymphocytes Negative 
288 
 
66 52 Negative Negative Lymphocytes Negative 
564 
 
78 40 Negative Negative Malignant Negative 
292 
 
64 56 Negative Negative Lymphocytes Negative 
278 
 
66 58 Negative Negative Lymphocytes Negative 
146 
 
36 66 Negative Negative Nil Negative 
298 
 
64 56 Negative Negative Neutrophil Positive Cocci 
294 
 
62 58 Negative Negative Neutrophil Negative 
146 
 
36 68 Negative Negative Nil Negative 
286 
 
64 52 Negative Negative Lymphocytes Negative 
316 
 
60 54 Negative Negative Neutrophil Negative 
284 
 
62 50 Negative Negative Lymphocytes Negative 
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SP.AFB CXR LIG_CRI LDH_CHOL ETIOLOGY 
Negative Right Plef Exudate exudate TB 
Negative Right Plef Exudate exudate TB 
Negative Left Plef Exudate Exudate Para Pneumonic 
Negative Right Plef Transudate Transudate CCF 
Negative Right Plef Exudate Exudate TB 
Negative Left Plef Exudate Exudate Malignancy 
Negative Right Plef Exudate Exudate TB 
Negative B/L Plef Transudate Exudate CCF 
Negative Left Plef Exudate Exudate Para Pneumonic 
Negative Right Plef Exudate Exudate TB 
Negative Left Plef Exudate Exudate Malignancy 
Negative Right Plef Exudate transudate TB 
Negative Left Plef Exudate Exudate Para Pneumonic 
Negative Right Plef Transudate Transudate CIRRHOSIS 
Negative Left Plef Exudate Exudate TB 
Negative B/L Plef Transudate Exudate CCF 
Negative Right Plef Exudate Exudate Empyema 
Negative B/L Plef Transudate Transudate CIRRHOSIS 
Negative Right Plef Exudate Exudate Para Pneumonic 
Negative Right Plef Exudate Exudate TB 
Negative Left Plef Exudate Exudate Malignancy 
Negative Right Plef Exudate Exudate TB 
Negative B/L Plef Transudate Transudate CIRRHOSIS 
Negative Right Plef Exudate Exudate TB 
Negative Right Plef Exudate Exudate Empyema 
Negative Right Plef Exudate Exudate Malignancy 
Negative Left Plef Exudate Exudate TB 
Negative Right Plef Exudate Exudate Para Pneumonic 
Negative Left Plef Exudate Exudate TB 
Negative Right Plef Transudate Transudate CCF 
Negative Left Plef Exudate Exudate Para Pneumonic 
Negative Right Plef Exudate transudate TB 
Negative Right Plef Exudate Exudate Para Pneumonic 
Negative Left Plef Exudate Exudate TB 
Negative Left Plef Exudate Exudate Malignancy 
Negative Right Plef Exudate Exudate TB 
Negative Right Plef Exudate Exudate Para Pneumonic 
Negative Right Plef Transudate Transudate CIRRHOSIS 
Negative Right Plef Exudate Exudate TB 
Negative Left Plef Exudate Exudate TB 
Negative Left Plef Exudate Exudate Malignancy 
Negative Right Plef Exudate Exudate TB 
Negative Right Plef Exudate Exudate TB 
Negative B/L Plef Transudate Transudate CCF 
Negative Left Plef Exudate Exudate Para Pneumonic 
Negative Right Plef Exudate Exudate Para Pneumonic 
Negative Right Plef Transudate Transudate CIRRHOSIS 
Negative Left Plef Exudate Exudate TB 
Negative Left Plef Exudate Exudate Para Pneumonic 
Negative Right Plef Exudate Exudate TB 
 
